Our Investment Strategy
Keev creates long-term value for clients through high selectivity and comprehensive monitoring over the investment cycle.
Cross Pollination
At Keev, we use cross-pollination as a strategic approach that leverages the knowledge, expertise, and resources across multiple portfolio companies to create value. It involves sharing best practices, innovations, or operational improvements from one company to another within the portfolio. This strategy can enhance the overall value of the portfolio, increase operational efficiencies, and improve the competitive positioning of the portfolio companies.
Knowledge Sharing and Best Practices
Operational
Improvements
Talent Sharing
and Development
Cross-Company
Collaboration
Technology and
Innovation Transfer
Financial
Synergies
Increased Market Access
Increased Value Creation
Improved Risk Management
| Strategy | Growth Equity | Mid Market Primary + Secondary | Listed Secondary | Senior Debt |
|---|---|---|---|---|
| Asset Allocation | 30% | 40% | 20% | 10% |
| Basic Thesis |
|
|
|
|
| Target IRR | 40% | 30% | 20% | 15% |
| Exit Timeline | 6 years | 4 years | 3 years | 3 years |
| Financial Profile | Revenue: $25–75M EBITDA: Breakeven/Positive | Revenue: $50–200M EBITDA: Positive | Revenue: $200–500M EBITDA & Cashflow: Positive | Portfolio Winners |
| Investment Size | Up to $8M | Up to $15M | Up to $20M | Up to $5M |
| Equity Stake | 10–15% | 8–10% | 3–8% | – |
| # of Portfolio Cos | 10–12 | 8–10 | 5–8 | 5 |
| Risk | High | Medium | Medium | Low |
A. Growth Late- Early stage Investing (Series A to C) > 30% of Corpus
Early-stage investing beyond Series A is an important area where Keev will focus their efforts to help companies scale and unlock their potential. At this stage, companies have typically passed the proof-of-concept phase and demonstrated product-market fit but require additional capital, expertise, and support to expand rapidly and solidify their position in the market.
Will provide larger, more strategic investments to help companies accelerate their growth trajectory, reach new markets, or expand product lines.
B. Mid stage Investing (Pre IPO) Primary + Secondary (40%)
C. Mid stage Investing (Pre IPO) Secondary
D. Listed Secondary
(20%)
E. Performance credit (Winners of portfolio) (10%)
